Use of Complementary Peptides and Their Antibodies in B-Cell-Mediated Autoimmune Disease: Prevention of Experimental Autoimmune Myasthenia Gravis with a Peptide Vaccine

ImmunoMethods ◽  
1994 ◽  
Vol 5 (2) ◽  
pp. 130-135 ◽  
Author(s):  
Shigeru Araga ◽  
J.Edwin Blalock
Keyword(s):  
Autoimmune Disease ◽  
Disease Prevention ◽  
Myasthenia Gravis ◽  
B Cell ◽  
Peptide Vaccine ◽  
Experimental Autoimmune Myasthenia Gravis ◽  
Autoimmune Myasthenia ◽  
Experimental Autoimmune

scholarly journals IL-17-producing CD4+T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis

2015 ◽  
Vol 45 (5) ◽  
pp. 1339-1347 ◽  
Author(s):  
Hanne Schaffert ◽  
Andreas Pelz ◽  
Abhishek Saxena ◽  
Mario Losen ◽  
Andreas Meisel ◽  
...  
Keyword(s):  
T Cells ◽  
Myasthenia Gravis ◽  
B Cell ◽  
Cd4 T Cells ◽  
Cell Tolerance ◽  
B Cell Tolerance ◽  
Experimental Autoimmune Myasthenia Gravis ◽  
Autoimmune Myasthenia ◽  
Experimental Autoimmune

A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help

2000 ◽  
Vol 14 (1) ◽  
pp. 185-196 ◽  
Author(s):  
SHIGERU ARAGA ◽  
LIKANG XU ◽  
KENJI NAKASHIMA ◽  
MATTEO VILLAIN ◽  
J. EDWIN BLALOCK
Keyword(s):  
T Cell ◽  
Myasthenia Gravis ◽  
Peptide Vaccine ◽  
Experimental Autoimmune Myasthenia Gravis ◽  
Autoimmune Myasthenia ◽  
T Cell Help ◽  
Experimental Autoimmune
Sign in / Sign up

Export Citation Format

Share Document